Literature DB >> 21092529

[Experts consensus on principles for diagnosis and treatment of neonatal jaundice].

.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 21092529

Source DB:  PubMed          Journal:  Zhonghua Er Ke Za Zhi        ISSN： 0578-1310


× No keyword cloud information.
  6 in total

1.  Multiple Genetic Modifiers of Bilirubin Metabolism Involvement in Significant Neonatal Hyperbilirubinemia in Patients of Chinese Descent.

Authors:  Hui Yang; Qian Wang; Lei Zheng; Min Lin; Xiang-bin Zheng; Fen Lin; Li-Ye Yang
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

2.  Systematic review of global clinical practice guidelines for neonatal hyperbilirubinemia.

Authors:  Meng Zhang; Jun Tang; Yang He; Wenxing Li; Zhong Chen; Tao Xiong; Yi Qu; Youping Li; Dezhi Mu
Journal:  BMJ Open       Date:  2021-01-19       Impact factor: 2.692

3.  Study on the Effect of Two Different Transfusion Methods in Neonates with Hyperbilirubinemia Induced by Non-Blood-Group Antibodies.

Authors:  Kunhai Wu; Lufei Chen; Huifang Huang
Journal:  Int J Gen Med       Date:  2021-10-28

4.  Clinical features and genetic variations of severe neonatal hyperbilirubinemia: Five case reports.

Authors:  Fen Lin; Jian-Xin Xu; Yong-Hao Wu; Yu-Bin Ma; Li-Ye Yang
Journal:  World J Clin Cases       Date:  2022-07-16       Impact factor: 1.534

5.  Maternal knowledge, attitudes and practices related to neonatal jaundice and associated factors in Shenzhen, China: a facility-based cross-sectional study.

Authors:  Ying Huang; Ling Chen; Xiaojiao Wang; Chun Zhao; Zonglian Guo; Jue Li; Fang Yang; Wenzhi Cai
Journal:  BMJ Open       Date:  2022-08-24       Impact factor: 3.006

6.  UGT1A1 mutation association with increased bilirubin levels and severity of unconjugated hyperbilirubinemia in ABO incompatible newborns of China.

Authors:  Hui Yang; Fen Lin; Zi-Kai Chen; Lin Zhang; Jia-Xin Xu; Yong-Hao Wu; Jing-Ying Gu; Yu-Bin Ma; Jian-Dong Li; Li-Ye Yang
Journal:  BMC Pediatr       Date:  2021-06-01       Impact factor: 2.125
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.